TNON icon

Tenon Medical

1.39 USD
-0.10
6.71%
At close Aug 25, 4:00 PM EDT
Pre-market
1.39
+0.00
0.00%
1 day
-6.71%
5 days
0.00%
1 month
31.13%
3 months
25.23%
6 months
6.11%
Year to date
-35.35%
1 year
-66.59%
5 years
-99.92%
10 years
-99.92%
 

About: Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

Employees: 27

0
Funds holding %
of 7,429 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

0.82% less ownership

Funds ownership: 2.46% [Q1] → 1.64% (-0.82%) [Q2]

21% less funds holding

Funds holding: 14 [Q1] → 11 (-3) [Q2]

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

62% less capital invested

Capital invested by funds: $322K [Q1] → $122K (-$200K) [Q2]

Research analyst outlook

We haven’t received any recent analyst ratings for TNON.

Financial journalist opinion

Based on 6 articles about TNON published over the past 30 days

Neutral
Accesswire
1 week ago
Tenon(R) Medical Announces the Full Market Launch of the Catamaran(R) SE SI Joint Fusion System
~Full Commercial Launch with Expanded Number of Instrument Sets and Field Support to Meet Growing Market Demand ~ ~ New SI Joint Fixation Device Offers a Reduced Profile in Implant Size Providing Physicians Choices for Varying Anatomy and Treatment Strategies with the Catamaran Technology ~ LOS GATOS, CA / ACCESS Newswire / August 19, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain sacro-pelvic disorders, today announced the full commercial market launch of its new Catamaran® SE SI Joint Fusion System. The Catamaran SE Fixation Device expands the Company's implant portfolio, providing physicians with a smaller implant option for sacroiliac (SI) joint fusion procedures.
Tenon(R) Medical Announces the Full Market Launch of the Catamaran(R) SE SI Joint Fusion System
Neutral
Seeking Alpha
1 week ago
Tenon Medical, Inc. (TNON) Q2 2025 Earnings Call Transcript
Tenon Medical, Inc. (NASDAQ:TNON ) Q2 2025 Earnings Conference Call August 13, 2025 4:30 PM ET Company Participants Kevin Williamson - Chief Financial Officer Steven M. Foster - CEO, President & Director Conference Call Participants Nicholas Sherwood - Maxim Group LLC, Research Division Scott Robert Henry - Alliance Global Partners, Research Division Operator Greetings, and welcome to the Tenon, Inc. Second Quarter 2025 Earnings Conference Call.
Tenon Medical, Inc. (TNON) Q2 2025 Earnings Call Transcript
Neutral
The Motley Fool
1 week ago
Tenon Medical (TNON) Q2 2025 Earnings Transcript
Image source: The Motley Fool.
Tenon Medical (TNON) Q2 2025 Earnings Transcript
Neutral
Accesswire
1 week ago
Tenon Medical Reports Second Quarter 2025 Financial Results
~ Recently Announced Strategic Acquisition of SiVantage Portfolio Energizes Tenon's Commercial Organization and Accelerates Topline Growth ~ ~ FDA Clearance Unlocks New Sacro-Pelvic Market Opportunity for Catamaran® as Adjunct to Thoracolumbar Fixation with Initial Case Series Successfully Completed ~ ~ Operating Expenses Down 29% Year-over-Year as Company Advances Toward Integration of SiVantage Assets, Addition of Commercial Team, and full Commercial Launch of Catamaran SE ~ ~ Cash on Hand of Approximately $7.8 Million at Quarter End ~ LOS GATOS, CA / ACCESS Newswire / August 13, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today reported financial results for the second quarter ended June 30, 2025. Financial Results and Business Updates Second Quarter 2025 Results: Revenue of $0.6 million, compared to $0.9 million in the second quarter of 2024.
Tenon Medical Reports Second Quarter 2025 Financial Results
Neutral
Accesswire
2 weeks ago
Tenon Medical, Inc. Announces Timing of Second Quarter 2025 Financial Results
LOS GATOS, CA / ACCESS Newswire / August 5, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced plans to release financial results for the second quarter 2025 ended June 30, 2025 after market close on Wednesday, August 13, 2025. The Company will also hold a conference call on the same day at 4:30 p.m.
Tenon Medical, Inc. Announces Timing of Second Quarter 2025 Financial Results
Neutral
Accesswire
3 weeks ago
Tenon Medical(R) Expands Sacro-Pelvic Fusion Portfolio with Strategic Asset Acquisition
~ SiVantage Portfolio Acquisition Enhances Tenon's Sacroiliac Joint Fusion Capabilities with a Unique Multi-Product, Multi-Approach Solution ~ ~ Significant Enhancement of Tenon Medical's Commercial Leadership to Accelerate Growth Initiatives ~ ~ Reinforces Tenon's Commitment to Fusion-Driven Innovation and Data-Backed Outcomes in a Rapidly Evolving Market ~ LOS GATOS, CA / ACCESS Newswire / August 1, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical technology company dedicated to transforming care for patients with sacroiliac joint (SIJ) disorders, today announced it has acquired sacroiliac (SI) joint specific assets from SiVantage, a privately held startup company based in Tampa, Florida. This strategic asset acquisition includes SiVantage's SImmetry® and SImmetry+™ technologies expanding Tenon's SI portfolio across multiple approaches to the variable sacro pelvic anatomy.
Tenon Medical(R) Expands Sacro-Pelvic Fusion Portfolio with Strategic Asset Acquisition
Neutral
Accesswire
2 months ago
Tenon Medical Announces Initial Case Series Utilizing Catamaran(R) SI Joint Fusion System to Enhance Stabilization of the SI Joint for Patients Undergoing Lumbar Fusion
~ Andrew J. Trontis, MD from Progressive Spine and Orthopaedics, (Englewood, NJ) Completes Initial Case Series ~ LOS GATOS, CA / ACCESS Newswire / June 12, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced the completion of an initial case series utilizing the Catamaran® SI Joint Fusion System (the "Catamaran") to immobilize & stabilize the SI Joint providing added support at the base of a lumbar or thoracolumbar fusion.
Tenon Medical Announces Initial Case Series Utilizing Catamaran(R) SI Joint Fusion System to Enhance Stabilization of the SI Joint for Patients Undergoing Lumbar Fusion
Neutral
Seeking Alpha
3 months ago
Tenon Medical, Inc. (TNON) Q1 2025 Earnings Call Transcript
Tenon Medical, Inc. (NASDAQ:TNON ) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Company Participants Steve Foster - President & Chief Executive Officer Kevin Williamson - Chief Financial Officer Conference Call Participants Scott Henry - Alliance Global Partners Nicholas Sherwood - Maxim Group Operator Greetings. And welcome to the Tenon Medical First Quarter 2025 Financial Results and Corporate Update Conference Call.
Tenon Medical, Inc. (TNON) Q1 2025 Earnings Call Transcript
Neutral
Accesswire
3 months ago
Tenon Medical Reports First Quarter 2025 Financial Results
~ FDA Clearance of Catamaran® SI Joint Fusion System for New Indication to Augment Spinal Fusion ~ ~ Catamaran® SI Joint Fusion Technology Protected with Robust Patent Portfolio of Twelve U.S. and International Patents ~ ~ Received Gross Proceeds of ~$7.0 Million from Equity Financing Transactions ~ ~ National Commercial Launch of Catamaran SE in Mid-2025 ~ LOS GATOS, CA / ACCESS Newswire / May 13, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today reported financial results for the first quarter ended March 31, 2025. Financial Results and Business Updates First Quarter 2025 Results: Revenue of $0.7 million, in line with the first quarter of 2024.
Tenon Medical Reports First Quarter 2025 Financial Results
Neutral
Accesswire
3 months ago
Tenon Medical, Inc. Announces Timing of First Quarter 2025 Financial Results
LOS GATOS, CA / ACCESS Newswire / April 29, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced plans to release financial results for the first quarter 2025 ended March 31, 2025 after market close on Tuesday, May 13, 2025. The Company will also hold a conference call on the same day at 4:30 p.m.
Tenon Medical, Inc. Announces Timing of First Quarter 2025 Financial Results
Charts implemented using Lightweight Charts™